Cargando…

Patients’ Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing

This paper explores patients’ views and experiences of undergoing treatment-focused BRCA1 and BRCA2 genetic testing (TFGT), either offered following triaging to clinical genetics (breast cancer) or as part of a mainstreamed care pathway in oncology (ovarian cancer). Drawing on 26 in-depth interviews...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wright, Sarah, Porteous, Mary, Stirling, Diane, Lawton, Julia, Young, Oliver, Gourley, Charlie, Hallowell, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209051/ https://www.ncbi.nlm.nih.gov/pubmed/29752676 http://dx.doi.org/10.1007/s10897-018-0261-5

Ejemplares similares

Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care
por: Hallowell, Nina, et al.
Publicado: (2019)

Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer
por: Kemp, Zoe, et al.
Publicado: (2019)

Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?
por: Ain, Quratul, et al.
Publicado: (2022)

BRCA1 testing
por: Górski, Bohdan, et al.
Publicado: (2008)

New challenges for BRCA testing: a view from the diagnostic laboratory
por: Wallace, Andrew J
Publicado: (2016)

BRCA Testing in Serbia and Montenegro
por: Brankovic-Magic, Mirjana
Publicado: (2006)

BRCA1 testing in Lithuania
por: Janavicius, Ramunas
Publicado: (2012)

Genetic testing for BRCA1 and BRCA2 mutations - ready for implementation?
por: Weber, BL
Publicado: (2000)

BRCA Testing Dichotomy in Saudi Arabia
por: Abusanad, Atlal
Publicado: (2019)

An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice
por: Ellison, Gillian, et al.
Publicado: (2017)

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
por: Toland, Amanda Ewart, et al.
Publicado: (2018)

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study
por: Girardi, Fabio, et al.
Publicado: (2018)

Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population
por: Wong, Edward S. Y., et al.
Publicado: (2015)

Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study
por: Mella, Sara, et al.
Publicado: (2017)

In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing
por: Poon, Kok-Siong
Publicado: (2021)

Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer
por: Hollis, Robert L, et al.
Publicado: (2017)

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
por: Bekos, Christine, et al.
Publicado: (2021)

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
por: Hollis, Robert L., et al.
Publicado: (2018)

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis
por: Dossa, Fahima, et al.
Publicado: (2021)

Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
por: Cham, Stephanie, et al.
Publicado: (2022)

Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
por: Nguyen-Dumont, Tu, et al.
Publicado: (2020)

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients
por: Lanjouw, Lieke, et al.
Publicado: (2023)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer
por: Karami, Fatemeh, et al.
Publicado: (2013)

UK BRCA mutation testing in patients with ovarian cancer
por: George, Angela
Publicado: (2015)

Practical consensus recommendation on when to do BRCA testing
por: Parikh, Purvish M., et al.
Publicado: (2018)

Cost-effective BRCA Testing in Advanced Ovarian Cancer
por: Kim, Myungshin
Publicado: (2023)

A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations
por: An, Q, et al.
Publicado: (2010)

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
por: Kang, Hyunseok P., et al.
Publicado: (2016)

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer
por: Eccleston, Anthony, et al.
Publicado: (2017)

An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia
por: Yuen, Jeanette, et al.
Publicado: (2020)

New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study
por: Plaskocinska, Inga, et al.
Publicado: (2016)

Oncologist-led BRCA ‘mainstreaming’ in the ovarian cancer clinic: A study of 255 patients and its impact on their management
por: Rumford, Megan, et al.
Publicado: (2020)

Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing
por: Vlessis, Katherine, et al.
Publicado: (2019)

BRCA testing and testing results among women 18–65 years old
por: Guo, Fangjian, et al.
Publicado: (2022)

Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing
por: Fallowfield, Lesley, et al.
Publicado: (2022)

Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of ‘easy to apply’ probability models
por: Bodmer, D, et al.
Publicado: (2006)

Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives
por: Ardern-Jones, Audrey, et al.
Publicado: (2010)

Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing
por: Shin, Saeam, et al.
Publicado: (2017)

Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
por: Manchanda, Ranjit, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_be048c63j1jom22eoqt82qe0a5